Amylin analogs

MX2026008977APending Publication Date: 2026-10-02VIKING THERAPEUTICS INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MX2026008977
Authority / Receiving Office: MX · MX
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2025-01-21
Filing Date: 2026-07-20
Publication Date: 2026-10-02

Application Information

Patent Timeline

21 Jan 2025

Priority

20 Jul 2026

Application

MX2026008977

02 Oct 2026

Publication

MX2026008977A

IPC: C07K14/575; A61K38/00; A61K38/22; A61P3/04; A61P3/06; A61P3/10; A61P9/12; A61P43/00

CPC: C07K14/575; A61P9/12; A61P43/00; A61P3/06; A61P3/04; A61P3/10; A61K38/00

Inventors: LIAN Brian; BARKER Geoffrey E.

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention encompasses polypeptides of Formula (I), and pharmaceutically acceptable salts thereof that are effective as amylin analogs. Amylin analogs of Formula (I) find use in the treatment of metabolic disorders or metabolic syndrome in a subject.

Need to check novelty before this filing date? Find Prior Art